Montana SB112 revises laws to prohibit state funds from purchasing opioid antagonists from certain entities after June 30, 2025.
Montana SB112 revises laws related to the state purchase of opioid antagonists, specifically prohibiting the use of state funds or available federal funding to purchase these drugs from entities involved in opioid settlements after June 30, 2025. The bill also prohibits the renewal of certain state contracts after June 30, 2025. It defines "opioid antagonist" and specifies that the act is effective immediately upon passage and approval.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.